0001209191-19-045647.txt : 20190812
0001209191-19-045647.hdr.sgml : 20190812
20190812194703
ACCESSION NUMBER: 0001209191-19-045647
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190809
FILED AS OF DATE: 20190812
DATE AS OF CHANGE: 20190812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fowler John Franklin
CENTRAL INDEX KEY: 0001744263
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 191017988
MAIL ADDRESS:
STREET 1: C/O KEZAR LIFE SCIENCES, INC.
STREET 2: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-09
0
0001645666
Kezar Life Sciences, Inc.
KZR
0001744263
Fowler John Franklin
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
CEO
Common Stock
2019-08-09
4
P
0
500
5.255
A
293204
D
Common Stock
2019-08-09
4
P
0
750
5.0147
A
293954
I
By Trust
The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.9642 to $5.1143 on August 9, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of issuer, full information regarding the number of shares purchased at each separate price.
/s/ Marc Belsky, Attorney-in-Fact
2019-08-12